• Librela is the first and only monthly monoclonal antibody injection to provide long-term canine osteoarthritis pain control
• Effectively controls canine osteoarthritis pain with a monthly injection
• Approved as safe and is metabolized and eliminated like naturally occurring antibodies, with minimal involvement of the liver or kidneys
• Works differently than NSAIDs by reducing NGF (nerve growth factor) effects, a key factor in canine osteoarthritis pain
• Reduced canine osteoarthritis pain, which led to increased activity and improved quality of life

Schedule an appointment to review the newest osteoarthritis injection for dogs.